Attached files

file filename
8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20141023x8k.htm
EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20141023ex992c80620.htm
EX-99.3 - EX-99.3 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20141023ex993a3ec47.htm

Exhibit 99.1

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30,

 

December 31,

(in thousands except par value amounts)

2014

 

2013

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

$

35,411 

 

$

26,362 

Investments

 

63,901 

 

 

86,166 

Accounts receivable

 

2,370 

 

 

2,746 

Inventory, net

 

11,398 

 

 

10,050 

Prepaid expenses and other current assets

 

1,057 

 

 

1,135 

Total current assets

 

114,137 

 

 

126,459 

Property and equipment, net

 

7,034 

 

 

9,236 

Other long-term assets

 

471 

 

 

490 

Total assets

$

121,642 

 

$

136,185 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

$

5,845 

 

$

1,717 

Accrued expenses

 

8,726 

 

 

7,905 

Deferred service revenue, current

 

5,307 

 

 

4,046 

Deferred contractual revenue, current

 

6,785 

 

 

6,785 

Other liabilities, current

 

2,477 

 

 

2,102 

Total current liabilities

 

29,140 

 

 

22,555 

Deferred service revenue, non-current

 

918 

 

 

518 

Deferred contractual revenue, non-current

 

21,431 

 

 

26,519 

Other liabilities, non-current

 

2,505 

 

 

3,517 

Notes payable

 

13,914 

 

 

13,347 

Financing derivative

 

699 

 

 

549 

Total liabilities

 

68,607 

 

 

67,005 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred Stock, $0.001 par value:

 

 

 

 

 

Authorized 50,000 shares; No shares issued or outstanding

 

 —

 

 

 —

Common Stock, $0.001 par value:

 

 

 

 

 

Authorized 1,000,000 shares; Issued and outstanding 70,976 shares at September 30, 2014 and 66,275 shares at December 31, 2013, respectively

 

71 

 

 

66 

Additional paid-in capital

 

715,439 

 

 

684,413 

Accumulated other comprehensive income

 

23 

 

 

14 

Accumulated deficit

 

(662,498)

 

 

(615,313)

Total stockholders’ equity

 

53,035 

 

 

69,180 

Total liabilities and stockholders’ equity

$

121,642 

 

$

136,185